AUA 2018 Lower Urinary Tract Conditions / Nocturia

Viewing 1-20 of 34 articles

AUA 2018: A Catheter Insertion Force Assessment Tool: Design and Preclinical Results

AUA 2018: Risk Factors Associated with Fecal Incontinence in Patients with Overactive Bladder

AUA 2018: Concomitant Procedures Performed at the Time of Midurethral Sling Affect Post Operative Urinary Retention Rate

AUA 2018: Impact of Lifetime Obesity on Urinary Incontinence in the Women’s Health Initiative

AUA 2018: The Utility of Urodynamic Evaluation in Clinical Practice

AUA 2018: Elevated Post-Void Residual Volumes, Not Associated with Self-Reported Urinary Tract Infections: A Report From The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN)

AUA 2018: Safety & Efficacy of the eCOIN™ Implantable Tibial Nerve Stimulation Device for Overactive Bladder Syndrome

AUA 2018: No Increased Risk of Clean Intermittent Catheterization with Onabotulinumtoxina Retreatment

AUA 2018: Onabotulinumtoxina Injection to the External Urethral Sphincter for Voiding Dysfunction in Females

AUA 2018: Bladder Neck Artificial Urinary Sphincter for Recurrent or Complex Primary Urodynamically Proven Stress and Mixed Urinary Incontinence

AUA 2018: Relationship Between Excess Visceral Fat Volume and Overactive Bladder

AUA 2018: Contemporary Review of Complications Associated with Autologous Rectus Fascia Pubovaginal Slings

AUA 2018: Efficacy and Safety of Add-on Mirabegron vs Placebo to Tamsulosin in Men with Overactive Bladder Symptoms MATCH Study

AUA 2018: Insomnia Induces Lower Urinary Tract Symptoms: The Natural History and Risk Factors for LUTS from the Nagahama Longitudinal Study

AUA 2018: Extended First Uninterrupted Sleep Period in Elderly Patients Following Treatment with AV002, an Emulsified Low Dose Vasopressin Analog for Nocturia

AUA 2018: The “Metabolic” Overactive Bladder Syndrome

AUA 2018: A Prospective Study to Evaluate Efficacy with the Nuro™ Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with Overactive Bladder Syndrome

AUA 2018: Underactive Bladder: Evaluation and Management

AUA 2018: OAB - Therapeutic Algorithm for Third-Line Therapies: When I Use What, and Why?

AUA 2018: Association Between Overactive Bladder Severity and Bold fMRI Brain Activity

1
2